ID GMPR_CAEEL Reviewed; 358 AA. AC O16294; DT 01-DEC-2000, integrated into UniProtKB/Swiss-Prot. DT 01-JAN-1998, sequence version 1. DT 16-JUN-2009, entry version 61. DE RecName: Full=Probable GMP reductase; DE EC=1.7.1.7; DE AltName: Full=Guanosine 5'-monophosphate oxidoreductase; DE Short=Guanosine monophosphate reductase; GN ORFNames=F32D1.5; OS Caenorhabditis elegans. OC Eukaryota; Metazoa; Nematoda; Chromadorea; Rhabditida; Rhabditoidea; OC Rhabditidae; Peloderinae; Caenorhabditis. OX NCBI_TaxID=6239; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=Bristol N2; RX MEDLINE=99069613; PubMed=9851916; DOI=10.1126/science.282.5396.2012; RG The C. elegans sequencing consortium; RT "Genome sequence of the nematode C. elegans: a platform for RT investigating biology."; RL Science 282:2012-2018(1998). CC -!- FUNCTION: Catalyzes the irreversible NADPH-dependent deamination CC of GMP to IMP. It functions in the conversion of nucleobase, CC nucleoside and nucleotide derivatives of G to A nucleotides, and CC in maintaining the intracellular balance of A and G nucleotides CC (By similarity). CC -!- CATALYTIC ACTIVITY: Inosine 5'-phosphate + NH(3) + NADP(+) = CC guanosine 5'-phosphate + NADPH. CC -!- SIMILARITY: Belongs to the IMPDH/GMPR family. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AF016427; AAB65350.1; -; Genomic_DNA. DR PIR; T03917; T03917. DR RefSeq; NP_504202.1; -. DR UniGene; Cel.6523; -. DR HSSP; P49058; 1EEP. DR SMR; O16294; 2-339. DR Ensembl; F32D1.5; Caenorhabditis elegans. DR GeneID; 178834; -. DR KEGG; cel:F32D1.5; -. DR WormBase; WBGene00017984; F32D1.5. DR WormPep; F32D1.5; CE09869. DR OMA; O16294; NSRSECD. DR BRENDA; 1.7.1.7; 672. DR NextBio; 902748; -. DR ArrayExpress; O16294; -. DR GO; GO:0003920; F:GMP reductase activity; IEA:EC. DR GO; GO:0030955; F:potassium ion binding; IEA:UniProtKB-KW. DR GO; GO:0009792; P:embryonic development ending in birth or eg...; IMP:WormBase. DR GO; GO:0040007; P:growth; IMP:WormBase. DR GO; GO:0002119; P:nematode larval development; IMP:WormBase. DR GO; GO:0009117; P:nucleotide metabolic process; IEA:InterPro. DR GO; GO:0055114; P:oxidation reduction; IEA:UniProtKB-KW. DR InterPro; IPR013785; Aldolase_TIM. DR InterPro; IPR005993; GMP_reduct1. DR InterPro; IPR015875; IMP_DH/GMP_Rdtase_CS. DR InterPro; IPR001093; IMP_DH_GMPRt. DR Gene3D; G3DSA:3.20.20.70; Aldolase_TIM; 1. DR Pfam; PF00478; IMPDH; 1. DR PIRSF; PIRSF000235; GMP_reductase; 1. DR TIGRFAMs; TIGR01305; GMP_reduct_1; 1. DR PROSITE; PS00487; IMP_DH_GMP_RED; 1. PE 2: Evidence at transcript level; KW Complete proteome; Metal-binding; NADP; Oxidoreductase; Potassium. FT CHAIN 1 358 Probable GMP reductase. FT /FTId=PRO_0000093729. FT NP_BIND 109 132 NADP (By similarity). FT ACT_SITE 187 187 Thioimidate intermediate (By similarity). FT METAL 182 182 Potassium; via carbonyl oxygen (By FT similarity). FT METAL 184 184 Potassium; via carbonyl oxygen (By FT similarity). FT BINDING 220 220 NADP (By similarity). SQ SEQUENCE 358 AA; 38806 MW; A4AEE84F2CB72360 CRC64; MPRIENEPKL DFKDVLLRPK RSTLKSRADV ELDREYVFRN SKATYTGVPV VASNMDTVGT FEMAAALNNH KIFTTIHKHY SVDEWKAFAA SASPDTFNNL AISSGISDND WTKLNTVITE LPQLKYICLD VANGYSESFV EFIRRVREAY PKHTIMAGNV VTGEMVEELI LSGADIVKVG IGPGSVCTTR KKAGVGYPQL SAVLECADAA HGLNGHVMSD GGCSNPGDVA KAFGAGADFV MIGGLFAGHD QSGGDLIEHN GKKFKLFYGM SSDTAMKKHH GSVAEYRASE GKTVTIPYRG DVNGTVQDIL GGIRSACTYT GAKHLKELAK RATFIRVTQQ TNDMYVPFEV PTVPAPSK //